Butterfly Network, Inc. (NYSE: BFLY) is a medical technology company that develops AI-powered handheld ultrasound devices, including its Butterfly iQ platform aimed at expanding point-of-care diagnostics. The company reached public markets through a merger with GX Acquisition Corp. II, a blank-check vehicle sponsored by GX Sponsor II LLC that completed its initial public offering in May 2020 via a 424B4 prospectus filed with the SEC. The de-SPAC transaction closed in February 2021, with the combined entity trading under the BFLY ticker on the New York Stock Exchange. Butterfly Network operates in the healthcare technology sector. Sign up on SpacDesk for full deal data, sponsor profiles, and post-merger analytics on BFLY and hundreds of other SPAC transactions.